Early clinical experience with imatinib in COVID-19: Searching for a dual effect.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/56332

Title:	Early clinical experience with imatinib in COVID-19: Searching for a dual effect.
Authors:	Morales-Ortega, Alejandro Rivas-Prado, Luis Frutos-Pérez, Begoña Jaenes-Barrios, Beatriz Farfán-Sedano, Ana Isabel García-Parra, Carlos Javier Hernández-Muniesa, Belén Duarte-Millán, Miguel Ángel Madroñal-Cerezo, Elena Ontañón-Nasarre, Ana Ruiz-Giardín, José Manuel Bermejo, Fernando García-Gil, Mario Gonzalo-Pascua, Sonia San Martín-López, Juan Víctor Bernal-Bello, David View more
Mesh:	Amides COVID-19 Humans Imatinib Mesylate Pyrazines SARS-CoV-2 Treatment Outcome View more
Issue Date:	5-Feb-2021
Citation:	J Infect.2021;(82)5:186-230
PMID:	33549625
URI:	https://hdl.handle.net/20.500.12530/56332
Rights:	openAccess
Appears in Collections:	Centros de Atención Primaria > Artículos

Files in This Item:

File	Size	Format
PMC7862035.pdf	6.86 MB	Adobe PDF	View/Open